Table 3.
distribution of the types of oral candidiasis according immuno-virological response among antiretroviral treatment naive and antiretroviral treatment treated patients
| Naive patients | Erythematous candidiasis | P-value | Pseudomembranous candidiasis | p-value | ||
|---|---|---|---|---|---|---|
| CD4 count (cells/mm3) | Yes (n, %) | No (n, %) | YES (n, %) | NO (n, %) | ||
| <200 | 7 (30.4) | 16 (69.6) | 0.002 | 4 (17.4) | 19 (82.6) | 0.03 |
| ≥ 200 | 0 (0.0) | 28 (100) | 0 (0.0) | 28 (100) | ||
| Viral load (copies/ml) | ||||||
| < 1000 | 1 (3.8) | 25 (96.1) | 0.04 | 0 (0.0) | 26 (100) | 0.05 |
| ≥ 1000 | 6 (24.0) | 19 (76.0) | 4(16.0) | 21(84.0) | ||
| Antiretroviral treatment treated patients | ||||||
| CD4 count (cells/mm3) | ||||||
| <200 | 2 (5.4) | 35 (94.5) | 0.65 | 1 (2.7) | 36 (97.3) | 0.33 |
| ≥ 200 | 4 (5.3) | 71 (94.6) | 0 (00) | 75 (100) | ||
| Viral load (copies/ml) | ||||||
| < 1000 | 2 (2.3) | 84 (97.6) | 0.02 | 0 (0.0) | 86 (100) | 0.23 |
| ≥ 1000 | 4 (15.4) | 22 (84.6) | 1 (3.8) | 25 (96.1) | ||